Torch

Faculty and Department

  • Faculty of Health Sciences
  • Hull York Medical School

Recent outputs

View more outputs

Journal Article

Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility

Naylor-Adamson, L., Price, T. W., Booth, Z., Stasiuk, G. J., & Calaminus, S. D. (2024). Quantum Dot Imaging Agents: Haematopoietic Cell Interactions and Biocompatibility. Cells, 13(4), Article 354. https://doi.org/10.3390/cells13040354

Impact of Surface Ligand on the Biocompatibility of InP/ZnS Quantum Dots with Platelets

Gil, H. M., Booth, Z., Price, T. W., Lee, J., Naylor‐Adamson, L., Avery, M., …Stasiuk, G. J. (in press). Impact of Surface Ligand on the Biocompatibility of InP/ZnS Quantum Dots with Platelets. Small, Article 2304881. https://doi.org/10.1002/smll.202304881

Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation

Coupland, C. A., Naylor-Adamson, L., Booth, Z., Price, T. W., Gil, H. M., Firth, G., …Calaminus, S. D. (2023). Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation. Journal of thrombosis and haemostasis : JTH, 21(9), 2545-2558. https://doi.org/10.1016/j.jtha.2023.05.008

Should aspirin be replaced with ADP blockers or anti-GPVI to manage thrombosis?

Khan, H., Ghulam, T., Ahmed, N., Babar, M. R., Calaminus, S. D., & Yusuf, M. Z. (2022). Should aspirin be replaced with ADP blockers or anti-GPVI to manage thrombosis?. Vascular Biology, https://doi.org/10.1530/vb-22-0010

Practical considerations of dissolved oxygen levels for platelet function under hypoxia

Kusanto, B., Gordon, A., Naylor-Adamson, L., Atkinson, L., Coupland, C., Booth, Z., …Arman, M. (2021). Practical considerations of dissolved oxygen levels for platelet function under hypoxia. International Journal of Molecular Sciences, 22(24), Article 13223. https://doi.org/10.3390/ijms222413223

Lead investigator

Project

Funder

Grant

Started

Status

Project

Is zinc a critical modulator of cyclic nucleotide signalling?

Funder

British Heart Foundation

Grant

£108,740.00

Started

1 October 2019

Status

Complete

Project

Platelet cAMP signalling controls thrombosis through enhanced embolisation

Funder

British Heart Foundation

Grant

£106,467.00

Started

1 October 2015

Status

Complete

Co-investigator

Project

Funder

Grant

Started

Status

Project

TARGETING THE MYOSIN LIGHT CHAIN PHOSPHATASE WITH PEPTIDE DISRUPTORS: A NOVEL ANTIPLATELET THERAPEUTIC APPROACH

Funder

British Heart Foundation

Grant

£110,680.00

Started

3 July 2023

Status

Ongoing

Project

ThrombiGlow: ‘Smart’ Multimodal Platelet Specific ‘Theranostic’ Drug Delivery Imaging

Funder

British Heart Foundation

Grant

£107,146.00

Started

1 February 2017

Status

Complete

Top